Why is Zydus Lifesci. falling/rising?

As of 26-Sep, Zydus Lifesciences Ltd is experiencing a decline in its stock price, currently at 976.05, which reflects a decrease of 42.85 points or 4.21%. The stock has underperformed its sector by 1.87% today and has been on a consecutive downward trend for the last three days, resulting in a total drop of 6.63% during this period. It opened with a loss of 2.78% and reached an intraday low of Rs 972. In terms of performance over different periods, the stock has seen a 1-week decline of 5.88% and a 1-year decline of 8.64%, while it has shown a positive return of 174.21% over the last three years. Despite these declines, the company maintains strong long-term fundamentals, with a low debt-to-equity ratio and consistent profitability, as indicated by a return on equity of 19.49%.
In the broader market context, Zydus Lifesciences Ltd's recent performance contrasts with the benchmark Sensex, which has fallen by 2.66% over the past week and 0.45% over the past month. The pharmaceuticals and drugs sector, in which Zydus operates, has also seen a decline of 2.34%. However, the stock's liquidity remains adequate, with a notable increase in delivery volume, suggesting rising investor participation despite the current price drop. The company's strong fundamentals, including healthy net sales growth and a solid cash position, indicate potential for recovery, but the recent price movements reflect market pressures and sector-wide challenges.